| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/08/2002 | WO2002011735A3 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002011671A3 Method of preparing stable bleached shellac |
| 08/08/2002 | WO2002011665A3 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2002000194A3 Polymeric micelle compositions |
| 08/08/2002 | WO2001095899A3 Pharmaceutical compositions comprising cannabidiol derivatives |
| 08/08/2002 | WO2001091814A3 Polyubiquitin based hydrogel and uses thereof |
| 08/08/2002 | WO2001085150A3 Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists |
| 08/08/2002 | WO2001064182A9 Improvements in or relating to the delivery of oral drugs |
| 08/08/2002 | WO2001010481A9 Drug dispensing system |
| 08/08/2002 | WO2001010406A3 Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow |
| 08/08/2002 | WO2001008636A8 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 08/08/2002 | WO2000074736A9 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| 08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
| 08/08/2002 | US20020107505 Modification of polypeptide drugs to increase electrotransport flux |
| 08/08/2002 | US20020107476 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
| 08/08/2002 | US20020107470 Microchip devices for delivery of molecules and methods of fabrication thereof |
| 08/08/2002 | US20020107436 Skin patch including a temperature sensor |
| 08/08/2002 | US20020107429 Compositions, devices, methods, and kits for induction of adhesions |
| 08/08/2002 | US20020107420 For use as excipient in pharmaceuticals and food processing; compressibility |
| 08/08/2002 | US20020107368 Helicobacter proteins, gene sequences and uses thereof |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107330 Drug delivery compositions and medical devices containing block copolymer |
| 08/08/2002 | US20020107292 Primary composition comprising a lipophilic bioactive compound |
| 08/08/2002 | US20020107291 Clear, injectable formulation of an anesthetic compound |
| 08/08/2002 | US20020107265 Emulsion comprising: (a) an aqueous phase; (b) an oil phase comprising a structured triglyceride; and (c) an emulsifier. |
| 08/08/2002 | US20020107260 Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
| 08/08/2002 | US20020107259 Analgesic combination of oxycodone and SC-58215 |
| 08/08/2002 | US20020107250 Orally deliverable cyclooxygenase-2 inhibitor of low water solubility, for example celecoxib, and a glycol ether, for example diethylene glycol monoethyl ether. |
| 08/08/2002 | US20020107238 Topical antibiotic composition for treatment of eye infection |
| 08/08/2002 | US20020107228 Topical bisphosphonates for prevention of bone resorption |
| 08/08/2002 | US20020107208 Gabapentin prodrugs and formulations |
| 08/08/2002 | US20020107206 Treatment of acute coronary syndrome with GLP-1 |
| 08/08/2002 | US20020107205 Exposing to a matrix of type I collagen and bone morphogenic protein-4 (BMP-4) |
| 08/08/2002 | US20020107200 Aqueous solution of parathyroid hormone, stabilizer such as mannitol, and buffering agent for acidic ph; shelf life |
| 08/08/2002 | US20020107183 Pharmaceutical preparations comprising cyclosporin for oral administration |
| 08/08/2002 | US20020106792 Immunoisolation of preferential cells; obtain cells, incubate with n-acetylglucosamine, encapsulate, recover cells |
| 08/08/2002 | US20020106461 Methods for coating particles and particles produced thereby |
| 08/08/2002 | US20020106412 Useful for printing pharmaceutical Oral Dosage Forms, attaining better control of the time release characteristics |
| 08/08/2002 | US20020106411 Mixing water-insoluble particle and a carrier; applying to area of a lumen or other body region in need of closure |
| 08/08/2002 | US20020106410 Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
| 08/08/2002 | US20020106409 Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use |
| 08/08/2002 | US20020106408 Prolamin-based sustained-release compositions and delayed-onset compositions |
| 08/08/2002 | US20020106407 Non-invasively delivering an analgesic into a patient's systemic circulation at an initial absorption rate, initial absorption rate; increasing absorption for therapy; providing analgesic to the patient's systemic circulation |
| 08/08/2002 | US20020106406 Crystallizable/non-crystallizable polymer composites |
| 08/08/2002 | US20020106405 Pharmaceutical composition for piperidinoalkanol compounds |
| 08/08/2002 | US20020106403 Dispersible phospholipid stabilized microparticles |
| 08/08/2002 | US20020106402 Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
| 08/08/2002 | US20020106401 Percutaneously absorptive preparation |
| 08/08/2002 | US20020106395 Sustained release drug delivery devices with prefabricated permeable plugs |
| 08/08/2002 | US20020106390 Use of nanodispersions in cosmetic end formulations |
| 08/08/2002 | US20020106368 Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same |
| 08/08/2002 | US20020106349 Dilute viral suspension is prepared corresponding to the dilution of a viral suspension in an aqueous solution containing salt or hexose; dilute viral suspension is nebulized pressurized gas of or an ultrasound frequency |
| 08/08/2002 | US20020106346 Administering to mammal polystyrene sulfonate as broad spectrum immune modulatory compound to modulate humeral and cellular arms of innate and adaptive immunity by modulation of compound selected from Factor H, Factor D, CD4 cells |
| 08/08/2002 | US20020106345 Therapeutic compositions and methods |
| 08/08/2002 | US20020106339 Compositions and methods using direct MMP inhibitors for inhibiting photoaging of skin |
| 08/08/2002 | US20020106337 Products for topical applications comprising oil bodies |
| 08/08/2002 | US20020106332 Process for preparing powder formulations |
| 08/08/2002 | US20020106331 Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols |
| 08/08/2002 | US20020106330 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/08/2002 | US20020106329 Transdermal dosage form |
| 08/08/2002 | US20020106304 Enhancing the anti-microbial activity of a borate-containing compound which comprises adding to the composition an effective amount of a low molecular weight amino alcohol, wherein the amino alcohol has a molecular weight of 60-200 |
| 08/08/2002 | DE10104880A1 Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen A multiparticulate pharmaceutical form comprising at least two differently coated pellet forms |
| 08/08/2002 | DE10104369A1 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz Using 2-amino- (4-hydroxy-2-methanesulfonamidophenyl) ethanol for treating urinary incontinence |
| 08/08/2002 | DE10104367A1 Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen Betamimetics containing pharmaceutical compositions with fewer side effects |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2437350A1 Pharmaceutical formulation |
| 08/08/2002 | CA2436776A1 Hydrogel wound dressing, preparation and use thereof |
| 08/08/2002 | CA2436429A1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | CA2436427A1 Compositions and method of tissue superoxygenation |
| 08/08/2002 | CA2436420A1 Resorbable bone cement containing active agents |
| 08/08/2002 | CA2436418A1 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | CA2436403A1 Anti-rubeola antibody for treating crohn's disease |
| 08/08/2002 | CA2436373A1 Pharmaceutical composition |
| 08/08/2002 | CA2435958A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | CA2435721A1 Production of capsules and particles for improvement of food products |
| 08/08/2002 | CA2435395A1 Enhanced ultrasound detection with temperature dependent contrast agents |
| 08/08/2002 | CA2434872A1 Medicament compositions with negligible side-effects containing betamimetics |
| 08/08/2002 | CA2434808A1 Novel mixtures of microbial enzymes |
| 08/08/2002 | CA2434565A1 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 08/08/2002 | CA2434485A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434242A1 Procedure and composition of treatment and/or care of the eye |
| 08/08/2002 | CA2433553A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | CA2430878A1 Anticholesterolemic edible oil |
| 08/07/2002 | EP1229112A1 Alpha-isomaltosylglucosaccharide synthase, process for producing the same and use thereof |
| 08/07/2002 | EP1229030A2 Hydrolysis-promoting taxane hydrophobic derivates |
| 08/07/2002 | EP1228772A1 Novel bone cement containing bioactive agents |
| 08/07/2002 | EP1228763A1 Multiparticulate formulations of lithium salts for once-a-day administration |
| 08/07/2002 | EP1228762A2 Method for preparation of disodium pamidronate |
| 08/07/2002 | EP1228761A2 Liquid pharmaceutical composition for treating bone diseases |
| 08/07/2002 | EP1228757A1 Stable pharmaceutical solutions of nimesulide |
| 08/07/2002 | EP1228755A1 Use of biodegradable microspheres for the delivery of an anticancer agent for the treatment of gliblastoma |
| 08/07/2002 | EP1228753A1 Herb bath |
| 08/07/2002 | EP1228236A2 Compositions for transfecting nucleic acids and their use |
| 08/07/2002 | EP1228199A2 Method for directed packaging of molecular substances in protein shells |
| 08/07/2002 | EP1228125A2 Process for making aqueous coated beadlets |
| 08/07/2002 | EP1228089A2 Salt form of a conjugate useful in the treatment of prostate cancer |
| 08/07/2002 | EP1228077A1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 08/07/2002 | EP1228044A2 Pyrrolo imidazole derivatives and their use as medicaments |